Megan Tan (Celebrity Host) with Daylong sunscreen products
Galderma, the Swiss-based global dermatology company, pioneering in dermatological solutions in the country launch Daylong™ sun protection the ultimate in daily skin protection with unrivalled scientific and dermartological expertise.
With its launch in Malaysia, Malaysians will finally be able to experience Daylong™ sun protection range of products. If you have an active lifestyle in the sun, check out this fully protected with medically proven Daylong™ sun protection.
There is no doubt that a little sunlight is good for you! The sun's rays provide warmth and light that enhance your general feeling of well being and stimulate blood circulation. Some UV radiation is essential to the body as it stimulates the production of vitamin D. However there are certain risks involved which might burn, hurt, and damage, and long-term exposure can lead to skin conditions including premature skin aging and cancer.
Daylong™ is a range of high-quality products offering reliable sun protection for diverse skin types and conditions for the whole family.
The products offering consists of Daylong™ SPF Gel fluid (30ml), Daylong™ SFT 50+ Gel (50ml), Daylong™ SPF 30 Spray (150ml), Daylong™ Kids SPF 30 Cream (50ml), Daylong™ Kids SPF 50+ Lotion (150ml) & Daylong™ After Sun Repair (100ml). This range of sun protection has advance filters and innovative formulations which provide effective protection with nurturing ingredients for long-lasting skin care.
“For 30 years, Galderma has always been highly committed in bringing the best innovations in medical dermatological solutions to meet the needs of consumers in more than 80 countries worldwide. With Daylong™ sun protection, consumers can look forward to optimal quality and exceptional protection for a healthy looking skin,” said Jean-Sebastien Ricard, General Manager of South East Asia of Galderma.
South East Asia of Galderma), Tey Hong Leng (Digital Manager of Guardian Malaysia),
Linda Cheng (Senior Category Manager - Merchandising of Guardian Malaysia), Jean-Sebastien Ricard (General Manager of South East Asia of Galderma) ,
Margaret Lau (Merchandising Director of Guardian Malaysia), Jesszlyn Tan (Assistant Manager – Merchandising of Guardian Malaysia), Joanne Leee (Area Manager - Operation of Guardian Malaysia) and
Tony Goh (Area Manager – Operation of Guardian Malaysia
Kenix Wong (Product Manager of Galderma Malaysia), Megan Tan (Celebrity Host), Jean-Sebastien Ricard (General Manager of South East Asia of Galderma) and Nael Itani (Self- Medication & Digital Manager South East Asia of Galderma)
L to R: Mr. Nael Itani (Self- Medication & Digital Manager South East Asia of Galderma)
and Aliza Sara (Lifestyle Blogger) during the Lucky Draw Prize Presentation
Daylong™ sun protection are easy to apply with a unique light unscented, fast absorbing, non-sticky, and very water-resistant formula that leaves no white spots. It is medically proven to protect skin cell DNA and help reduce the affects of sun-induced skin aging.
The range of sun protection provides optimal quality and exceptional protection to prevent sun damage and maintain fair, unblemished, healthy looking skin.
The protective effects of Daylong™ sun protection's advanced filters and innovative formulas go beyond regulatory requirements.
The Daylong Sun Protection Advantage
Cosmetic evaluations
- Proven high degree of skin tolerance
- Good absorbance
-Superb in-use skin feeling
Scientific evaluations
- Proven prevention of cell damage including protection against UV based radicals
- Proven protection of cellular DNA
- Successful reduction of cell aging processes caused by sunlight
- Confirmed effective protection against cell and tissue damage caused by IR radation
Daylong™ complete range products are now available at all major phamarcies, such as Guardian.
Products retail from RM90.80 to RM109.30.
About Galderma
For over 30 years, all our resources have been channelled in a single direction: to provide
innovative medical dermatological solutions that meet the needs of patients and physicians with a
particular focus on acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis (fungal nail infections), pigmentary disorders, skin cancer and medical aesthetic and corrective solutions for skin senescence. The skin conditions we treat can have
strong psychological and social implications in the everyday lives of our patients. By treating these
conditions, we help people preserve, restore and maintain healthy skin and improve their quality of life.
innovative medical dermatological solutions that meet the needs of patients and physicians with a
particular focus on acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis (fungal nail infections), pigmentary disorders, skin cancer and medical aesthetic and corrective solutions for skin senescence. The skin conditions we treat can have
strong psychological and social implications in the everyday lives of our patients. By treating these
conditions, we help people preserve, restore and maintain healthy skin and improve their quality of life.
Today, Galderma is a global dermatology company, with headquarter based in Switzerland, committed to delivering innovative medical solutions to meet the needs of people throughout their lifetime while
serving healthcare professionals around the world. The company has 33 wholly-owned affiliates and a worldwide network of distributors, approximately 5 000 employees and an
extensive product portfolio available in 80 countries. With approximately 19% of revenues invested
each year to discover and develop new dermatology solutions and products and access innovative
technologies, this company is one of the world’s leading investors in dermatology R&D.
Five R&D centres and five manufacturing sites are dedicated to providing a wide range of innovative medical solutions which meet the highest standards of safety and efficacy.
serving healthcare professionals around the world. The company has 33 wholly-owned affiliates and a worldwide network of distributors, approximately 5 000 employees and an
extensive product portfolio available in 80 countries. With approximately 19% of revenues invested
each year to discover and develop new dermatology solutions and products and access innovative
technologies, this company is one of the world’s leading investors in dermatology R&D.
Five R&D centres and five manufacturing sites are dedicated to providing a wide range of innovative medical solutions which meet the highest standards of safety and efficacy.
Waaahhhh ... interesting... Megan Tan is pretty....
ReplyDelete